Early development of intractable epilepsy in children : A prospective study

Little is known about early prediction of intractable epilepsy (IE) in children. Such information could help guide the early use of new therapies in selected patients. Children with newly diagnosed epilepsy (n = 613) were prospectively identified from child neurology practices in Connecticut (1993--...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurology 2001-06, Vol.56 (11), p.1445-1452
Hauptverfasser: BERG, A. T, SHINNAR, S, LEVY, S. R, TESTA, F. M, SMITH-RAPAPORT, S, BECKERMAN, B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1452
container_issue 11
container_start_page 1445
container_title Neurology
container_volume 56
creator BERG, A. T
SHINNAR, S
LEVY, S. R
TESTA, F. M
SMITH-RAPAPORT, S
BECKERMAN, B
description Little is known about early prediction of intractable epilepsy (IE) in children. Such information could help guide the early use of new therapies in selected patients. Children with newly diagnosed epilepsy (n = 613) were prospectively identified from child neurology practices in Connecticut (1993--1997) and followed-up for the occurrence of IE (failure of > or = 2 drugs, > or = 1 seizure/month, over 18 months) [corrected]. Etiology and epilepsy syndromes were classified per International League Against Epilepsy guidelines. The median follow-up is 4.8 years, and 599 (97.7%) have been followed for more than 18 months. Sixty children (10.0%) have met the criteria for IE, including 34.6% with cryptogenic/symptomatic generalized, 2.7% with idiopathic, 10.7% with other localization-related, and 8.2% with unclassified epilepsy (p < 0.0001). After multivariable adjustment for epilepsy syndrome, initial seizure frequency (p < 0.0001), focal EEG slowing (p = 0.02), and acute symptomatic or neonatal status epilepticus (p = 0.001) were associated with an increased risk of IE, and age at onset between 5 and 9 years was associated with a lowered risk (p = 0.03). The absolute number of seizures and unprovoked or febrile status epilepticus were not associated substantially with IE. Approximately 10% of children meet criteria for IE early in the course of their epilepsy. Cryptogenic/symptomatic generalized syndromes carry the highest risk and idiopathic syndromes the lowest. Half of IE occurs in children with nonidiopathic localization-related syndromes. Initial seizure frequency is highly predictive of IE. By contrast, absolute number of seizures and unprovoked or febrile status epilepticus are not.
doi_str_mv 10.1212/WNL.56.11.1445
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70948258</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70948258</sourcerecordid><originalsourceid>FETCH-LOGICAL-c320t-7ce8aba53bfe3bc320713f8f8d8e888880925158f76e754625ade07d3397c62e3</originalsourceid><addsrcrecordid>eNpNkEtLxDAUhYMozji6dSlZiLvWPJomdTcM4wMH3Si6C2l6i5X0YdMO9N_bMgW9mwvnfvdwOAhdUhJSRtntx8suFHFIaUijSByhJRUsDmLOPo_RkhCmAq6kWqAz778JGY8yOUULSiPCSJIs0fPWtG7AGezB1U0JVYfrHBdV1xrbmdQBhqZw0PhhFLH9KlzWQoXv8Bo3be0bsF2xB-y7PhvO0UlunIeLea_Q-_32bfMY7F4fnjbrXWA5I10gLSiTGsHTHHg6aZLyXOUqU6CmIQkTVKhcxiBFFDNhMiAy4zyRNmbAV-jm4Dsm-OnBd7osvAXnTAV177UkSaSYUCMYHkA7RvUt5Lppi9K0g6ZET_XpsT4tYk2pnuobH65m5z4tIfvD575G4HoGjLfG5a2pbOH_2ZJYUMp_AVFRd0M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70948258</pqid></control><display><type>article</type><title>Early development of intractable epilepsy in children : A prospective study</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>BERG, A. T ; SHINNAR, S ; LEVY, S. R ; TESTA, F. M ; SMITH-RAPAPORT, S ; BECKERMAN, B</creator><creatorcontrib>BERG, A. T ; SHINNAR, S ; LEVY, S. R ; TESTA, F. M ; SMITH-RAPAPORT, S ; BECKERMAN, B</creatorcontrib><description>Little is known about early prediction of intractable epilepsy (IE) in children. Such information could help guide the early use of new therapies in selected patients. Children with newly diagnosed epilepsy (n = 613) were prospectively identified from child neurology practices in Connecticut (1993--1997) and followed-up for the occurrence of IE (failure of &gt; or = 2 drugs, &gt; or = 1 seizure/month, over 18 months) [corrected]. Etiology and epilepsy syndromes were classified per International League Against Epilepsy guidelines. The median follow-up is 4.8 years, and 599 (97.7%) have been followed for more than 18 months. Sixty children (10.0%) have met the criteria for IE, including 34.6% with cryptogenic/symptomatic generalized, 2.7% with idiopathic, 10.7% with other localization-related, and 8.2% with unclassified epilepsy (p &lt; 0.0001). After multivariable adjustment for epilepsy syndrome, initial seizure frequency (p &lt; 0.0001), focal EEG slowing (p = 0.02), and acute symptomatic or neonatal status epilepticus (p = 0.001) were associated with an increased risk of IE, and age at onset between 5 and 9 years was associated with a lowered risk (p = 0.03). The absolute number of seizures and unprovoked or febrile status epilepticus were not associated substantially with IE. Approximately 10% of children meet criteria for IE early in the course of their epilepsy. Cryptogenic/symptomatic generalized syndromes carry the highest risk and idiopathic syndromes the lowest. Half of IE occurs in children with nonidiopathic localization-related syndromes. Initial seizure frequency is highly predictive of IE. By contrast, absolute number of seizures and unprovoked or febrile status epilepticus are not.</description><identifier>ISSN: 0028-3878</identifier><identifier>EISSN: 1526-632X</identifier><identifier>DOI: 10.1212/WNL.56.11.1445</identifier><identifier>PMID: 11402099</identifier><identifier>CODEN: NEURAI</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Age of Onset ; Anticonvulsants - therapeutic use ; Biological and medical sciences ; Child ; Child, Preschool ; Electroencephalography ; Female ; Follow-Up Studies ; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy ; Humans ; Infant ; Male ; Medical sciences ; Multivariate Analysis ; Nervous system (semeiology, syndromes) ; Neurology ; Predictive Value of Tests ; Prognosis ; Prospective Studies ; Risk Factors ; Seizures, Febrile - diagnosis ; Seizures, Febrile - drug therapy ; Status Epilepticus - diagnosis ; Status Epilepticus - drug therapy ; Status Epilepticus - epidemiology ; Treatment Failure</subject><ispartof>Neurology, 2001-06, Vol.56 (11), p.1445-1452</ispartof><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c320t-7ce8aba53bfe3bc320713f8f8d8e888880925158f76e754625ade07d3397c62e3</citedby><cites>FETCH-LOGICAL-c320t-7ce8aba53bfe3bc320713f8f8d8e888880925158f76e754625ade07d3397c62e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1006511$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11402099$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BERG, A. T</creatorcontrib><creatorcontrib>SHINNAR, S</creatorcontrib><creatorcontrib>LEVY, S. R</creatorcontrib><creatorcontrib>TESTA, F. M</creatorcontrib><creatorcontrib>SMITH-RAPAPORT, S</creatorcontrib><creatorcontrib>BECKERMAN, B</creatorcontrib><title>Early development of intractable epilepsy in children : A prospective study</title><title>Neurology</title><addtitle>Neurology</addtitle><description>Little is known about early prediction of intractable epilepsy (IE) in children. Such information could help guide the early use of new therapies in selected patients. Children with newly diagnosed epilepsy (n = 613) were prospectively identified from child neurology practices in Connecticut (1993--1997) and followed-up for the occurrence of IE (failure of &gt; or = 2 drugs, &gt; or = 1 seizure/month, over 18 months) [corrected]. Etiology and epilepsy syndromes were classified per International League Against Epilepsy guidelines. The median follow-up is 4.8 years, and 599 (97.7%) have been followed for more than 18 months. Sixty children (10.0%) have met the criteria for IE, including 34.6% with cryptogenic/symptomatic generalized, 2.7% with idiopathic, 10.7% with other localization-related, and 8.2% with unclassified epilepsy (p &lt; 0.0001). After multivariable adjustment for epilepsy syndrome, initial seizure frequency (p &lt; 0.0001), focal EEG slowing (p = 0.02), and acute symptomatic or neonatal status epilepticus (p = 0.001) were associated with an increased risk of IE, and age at onset between 5 and 9 years was associated with a lowered risk (p = 0.03). The absolute number of seizures and unprovoked or febrile status epilepticus were not associated substantially with IE. Approximately 10% of children meet criteria for IE early in the course of their epilepsy. Cryptogenic/symptomatic generalized syndromes carry the highest risk and idiopathic syndromes the lowest. Half of IE occurs in children with nonidiopathic localization-related syndromes. Initial seizure frequency is highly predictive of IE. By contrast, absolute number of seizures and unprovoked or febrile status epilepticus are not.</description><subject>Age of Onset</subject><subject>Anticonvulsants - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Electroencephalography</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</subject><subject>Humans</subject><subject>Infant</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Multivariate Analysis</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Risk Factors</subject><subject>Seizures, Febrile - diagnosis</subject><subject>Seizures, Febrile - drug therapy</subject><subject>Status Epilepticus - diagnosis</subject><subject>Status Epilepticus - drug therapy</subject><subject>Status Epilepticus - epidemiology</subject><subject>Treatment Failure</subject><issn>0028-3878</issn><issn>1526-632X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkEtLxDAUhYMozji6dSlZiLvWPJomdTcM4wMH3Si6C2l6i5X0YdMO9N_bMgW9mwvnfvdwOAhdUhJSRtntx8suFHFIaUijSByhJRUsDmLOPo_RkhCmAq6kWqAz778JGY8yOUULSiPCSJIs0fPWtG7AGezB1U0JVYfrHBdV1xrbmdQBhqZw0PhhFLH9KlzWQoXv8Bo3be0bsF2xB-y7PhvO0UlunIeLea_Q-_32bfMY7F4fnjbrXWA5I10gLSiTGsHTHHg6aZLyXOUqU6CmIQkTVKhcxiBFFDNhMiAy4zyRNmbAV-jm4Dsm-OnBd7osvAXnTAV177UkSaSYUCMYHkA7RvUt5Lppi9K0g6ZET_XpsT4tYk2pnuobH65m5z4tIfvD575G4HoGjLfG5a2pbOH_2ZJYUMp_AVFRd0M</recordid><startdate>20010612</startdate><enddate>20010612</enddate><creator>BERG, A. T</creator><creator>SHINNAR, S</creator><creator>LEVY, S. R</creator><creator>TESTA, F. M</creator><creator>SMITH-RAPAPORT, S</creator><creator>BECKERMAN, B</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010612</creationdate><title>Early development of intractable epilepsy in children : A prospective study</title><author>BERG, A. T ; SHINNAR, S ; LEVY, S. R ; TESTA, F. M ; SMITH-RAPAPORT, S ; BECKERMAN, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c320t-7ce8aba53bfe3bc320713f8f8d8e888880925158f76e754625ade07d3397c62e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Age of Onset</topic><topic>Anticonvulsants - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Electroencephalography</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</topic><topic>Humans</topic><topic>Infant</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Multivariate Analysis</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Risk Factors</topic><topic>Seizures, Febrile - diagnosis</topic><topic>Seizures, Febrile - drug therapy</topic><topic>Status Epilepticus - diagnosis</topic><topic>Status Epilepticus - drug therapy</topic><topic>Status Epilepticus - epidemiology</topic><topic>Treatment Failure</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BERG, A. T</creatorcontrib><creatorcontrib>SHINNAR, S</creatorcontrib><creatorcontrib>LEVY, S. R</creatorcontrib><creatorcontrib>TESTA, F. M</creatorcontrib><creatorcontrib>SMITH-RAPAPORT, S</creatorcontrib><creatorcontrib>BECKERMAN, B</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BERG, A. T</au><au>SHINNAR, S</au><au>LEVY, S. R</au><au>TESTA, F. M</au><au>SMITH-RAPAPORT, S</au><au>BECKERMAN, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Early development of intractable epilepsy in children : A prospective study</atitle><jtitle>Neurology</jtitle><addtitle>Neurology</addtitle><date>2001-06-12</date><risdate>2001</risdate><volume>56</volume><issue>11</issue><spage>1445</spage><epage>1452</epage><pages>1445-1452</pages><issn>0028-3878</issn><eissn>1526-632X</eissn><coden>NEURAI</coden><abstract>Little is known about early prediction of intractable epilepsy (IE) in children. Such information could help guide the early use of new therapies in selected patients. Children with newly diagnosed epilepsy (n = 613) were prospectively identified from child neurology practices in Connecticut (1993--1997) and followed-up for the occurrence of IE (failure of &gt; or = 2 drugs, &gt; or = 1 seizure/month, over 18 months) [corrected]. Etiology and epilepsy syndromes were classified per International League Against Epilepsy guidelines. The median follow-up is 4.8 years, and 599 (97.7%) have been followed for more than 18 months. Sixty children (10.0%) have met the criteria for IE, including 34.6% with cryptogenic/symptomatic generalized, 2.7% with idiopathic, 10.7% with other localization-related, and 8.2% with unclassified epilepsy (p &lt; 0.0001). After multivariable adjustment for epilepsy syndrome, initial seizure frequency (p &lt; 0.0001), focal EEG slowing (p = 0.02), and acute symptomatic or neonatal status epilepticus (p = 0.001) were associated with an increased risk of IE, and age at onset between 5 and 9 years was associated with a lowered risk (p = 0.03). The absolute number of seizures and unprovoked or febrile status epilepticus were not associated substantially with IE. Approximately 10% of children meet criteria for IE early in the course of their epilepsy. Cryptogenic/symptomatic generalized syndromes carry the highest risk and idiopathic syndromes the lowest. Half of IE occurs in children with nonidiopathic localization-related syndromes. Initial seizure frequency is highly predictive of IE. By contrast, absolute number of seizures and unprovoked or febrile status epilepticus are not.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>11402099</pmid><doi>10.1212/WNL.56.11.1445</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-3878
ispartof Neurology, 2001-06, Vol.56 (11), p.1445-1452
issn 0028-3878
1526-632X
language eng
recordid cdi_proquest_miscellaneous_70948258
source MEDLINE; Journals@Ovid Complete; Alma/SFX Local Collection
subjects Age of Onset
Anticonvulsants - therapeutic use
Biological and medical sciences
Child
Child, Preschool
Electroencephalography
Female
Follow-Up Studies
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
Humans
Infant
Male
Medical sciences
Multivariate Analysis
Nervous system (semeiology, syndromes)
Neurology
Predictive Value of Tests
Prognosis
Prospective Studies
Risk Factors
Seizures, Febrile - diagnosis
Seizures, Febrile - drug therapy
Status Epilepticus - diagnosis
Status Epilepticus - drug therapy
Status Epilepticus - epidemiology
Treatment Failure
title Early development of intractable epilepsy in children : A prospective study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T01%3A07%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Early%20development%20of%20intractable%20epilepsy%20in%20children%20:%20A%20prospective%20study&rft.jtitle=Neurology&rft.au=BERG,%20A.%20T&rft.date=2001-06-12&rft.volume=56&rft.issue=11&rft.spage=1445&rft.epage=1452&rft.pages=1445-1452&rft.issn=0028-3878&rft.eissn=1526-632X&rft.coden=NEURAI&rft_id=info:doi/10.1212/WNL.56.11.1445&rft_dat=%3Cproquest_cross%3E70948258%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70948258&rft_id=info:pmid/11402099&rfr_iscdi=true